1028739-93-6

Basic information

• Product Name: 4'-{[2-methyl-1-(2-methyl-2,3-dihydro-1-benzofuran-5-yl)-6-oxo-4-propyl-1,6-dihydropyrimidin-5-yl]methyl}biphenyl-2-carbonitrile
• Synonyms: 4'-{[2-methyl-1-(2-methyl-2,3-dihydro-1-benzofuran-5-yl)-6-oxo-4-propyl-1,6-dihydropyrimidin-5-yl]methyl}biphenyl-2-carbonitrile
• CAS NO: 1028739-93-6
• Molecular Weight: 475.59
• Mol File: 1028739-93-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4'-{[2-methyl-1-(2-methyl-2,3-dihydro-1-benzofuran-5-yl)-6-oxo-4-propyl-1,6-dihydropyrimidin-5-yl]methyl}biphenyl-2-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-{[2-methyl-1-(2-methyl-2,3-dihydro-1-benzofuran-5-yl)-6-oxo-4-propyl-1,6-dihydropyrimidin-5-yl]methyl}biphenyl-2-carbonitrile(1028739-93-6)
• EPA Substance Registry System: 4'-{[2-methyl-1-(2-methyl-2,3-dihydro-1-benzofuran-5-yl)-6-oxo-4-propyl-1,6-dihydropyrimidin-5-yl]methyl}biphenyl-2-carbonitrile(1028739-93-6)

Safety Data

• Hazardous Substances Data: 1028739-93-6(Hazardous Substances Data)

Upstream product

• 1028748-11-9 2-methyl-2,3-dihydrobenzofuran-5-ylboronic acid 
• 135689-67-7 5-<(2'-cyanobiphenyl-4-yl)methyl>-2-methyl-6-n-propylpyrimidin-4(3H)-one 

Downstream Products

• 1028711-67-2 2-methyl-3-(2-methyl-2,3-dihydro-1-benzofuran-5-yl)-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H)-one 

Relevant articles and documents

HETEROMONOCYCLIC COMPOUND AND USE THEREOF

A compound represented by the formula (I): wherein R1 is an oxo group, =N-R or the like; a group represented by the formula: is a group represented by the formula:;R2 is a group represented by the formula:;R3 and R4 are each H, or C1-C6 alkyl, C3-C6 cycloalkyl, C1-C6 alkoxy, C1-C6 alkylamino, di(C1-C6)alkylamino or C1-C6 alkylthio, each of which is optionally substituted; and R5 is H, or C1-C6 alkyl, C2-C6 alkenyl, cyclic group, each of which is optionally substituted, -CO-R8 or -O-R8', or a salt thereof. The compound of the present invention is useful as a drug for the prophylaxis or treatment of circulatory diseases, metabolic diseases and/or central nervous system diseases.